Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Head-to-head comparison of Oxytocin and PT-141 — mechanism, side effects, legal status, and pricing.
Oxytocin is a nine-amino acid peptide hormone (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, with a disulfide bridge between Cys1 and Cys6) produced in the hypothalamic paraventricular and supraoptic nuclei. The synthetic form (Pitocin) is FDA-approved as IV/IM injection for labor induction/augmentation and postpartum hemorrhage control. Intranasal oxytocin is NOT FDA-approved and is used off-label or in research settings for social/behavioral indications, where evidence is mixed.
PT-141 (bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from melanotan II. It is FDA-approved as Vyleesi (2019) for hypoactive sexual desire disorder (HSDD) in premenopausal women only. It acts centrally through the melanocortin system rather than on peripheral vasculature.
Oxytocin
PT-141
Category
Legal Status
Mechanism
Half-life
Side Effects
COA-verified vendors · trust score ≥70 required · single-vial price — bulk/bundle deals may be lower
Oxytocin
PT-141
COA corpus from Disclosed Labs — independently tested batches only.
Oxytocin
32
COAs
99.0%
Avg purity
9
Labs
PT-141
83
COAs
99.7%
Avg purity
14
Labs
Pitocin has decades of obstetric use under its FDA label. Intranasal oxytocin has been studied in dozens of RCTs across autism, social anxiety, PTSD, and schizophrenia. Evidence is MIXED and frequently negative for larger/more rigorous trials. Sikich et al. 2021 (NEJM, SOARS-B, PMID 34644471) — the largest placebo-controlled RCT (N=290) of intranasal oxytocin for autism — found no significant benefit over placebo on social or cognitive functioning over 24 weeks. Ooi et al. 2017 meta-analysis (PMID 27574858) found no significant overall effect of oxytocin on social cognition or repetitive behaviors in ASD. Leng & Ludwig 2016 'Intranasal Oxytocin: Myths and Delusions' (Biological Psychiatry, PMID 26049207) estimate <0.005% of intranasal dose reaches CSF, questioning the pharmacologic basis for reported behavioral effects. Marketing of intranasal oxytocin as a 'love/bonding' compound is not supported by the strongest clinical evidence. Pitocin FDA label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018261s031lbl.pdf
Key references
Bremelanotide received FDA approval in June 2019 (NDA 210557) based on the two Phase III RECONNECT trials reported by Kingsberg, Simon, Clayton, Portman et al. in Obstet Gynecol 2019 (PMID 31599840). Pooled 24-week data showed statistically significant increases in the Female Sexual Function Index desire domain and decreases in the Female Sexual Distress Scale compared with placebo, with long-term 52-week open-label safety reported in the companion paper (PMID 31599847). Earlier clinical programs in men with erectile dysfunction — including intranasal bremelanotide and the subcutaneous sildenafil-salvage study by Safarinejad & Hosseini (J Urol 2008, PMID 18206919) — showed modest efficacy but did not lead to approval in men. Safety monitoring shows transient SBP elevation (~6 mmHg) with reflex bradycardia resolving within ~12 hours; nausea (~40%) is the most common adverse event and typically diminishes with subsequent doses. Focal hyperpigmentation has been reported with repeated use, consistent with MC1R activity.
Oxytocin and PT-141 are both in the Hormone category and may have overlapping mechanisms. Researchers should review both profiles carefully, understand the mechanisms of action, and monitor the relevant biomarkers when combining compounds in the same class. As always, consult a licensed healthcare provider before making any decisions about combining research compounds.
This platform provides informational tools only, not medical advice. This comparison is for educational purposes only. Consult a licensed provider.
Contraindications
Lab Testing
Disclosed Labs